Antonio Delgado-Gonzalez

Antonio Delgado-Gonzalez

Auto-generated profile, based on publicly available information

Antonio Delgado-Gonzalez

Department of Pathology, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
BZBokai Zhu
Bokai Zhu
YBYunhao Bai
Yunhao Bai
YYYao Yu Yeo
Yao Yu Yeo
XLXiaowei Lu
Xiaowei Lu
XRXavier Rovira-Clavé
Xavier Rovira-Clavé
SJSizun Jiang
Sizun Jiang
The intricate interactions between the host immune system and its microbiome constituents undergo dynamic shifts in response to perturbations to the intestinal tissue environment. Our ability to study these events on the systems level is significantly limited by in situ approaches capable of generating simultaneous insights from both host and microbial communities. Here, we introduce Microbiome Cartography (MicroCart), a framework for simultaneous in situ probing of host and microbiome across multiple spatial modalities. We demonstrate MicroCart by investigating gut host and microbiome changes in a murine colitis model, using spatial proteomics, transcriptomics, and glycomics. Our findings reveal a global but systematic transformation in tissue immune responses, encompassing tissue-level remodeling in response to host immune and epithelial cell state perturbations, bacterial population shifts, localized inflammatory responses, and metabolic process alterations during colitis. MicroCart enables a deep investigation of the intricate interplay between the host tissue and its microbiome with spatial multi-omics.

1 August 2019 in Talanta
Verified
Journal Article
Closed access
ADAntonio Delgado-Gonzalez
Antonio Delgado-Gonzalez
ARAgustin Robles-Remacho
Agustin Robles-Remacho
AMAntonio Marin-Romero
Antonio Marin-Romero
SDSimone Detassis
Simone Detassis
BLBarbara Lopez-Longarela
Barbara Lopez-Longarela
JDJuan Díaz-mochon
Juan Díaz-mochon

5 January 2018 in ACS Omega
Verified
Journal Article
Open access
ADAntonio Delgado-Gonzalez
Antonio Delgado-Gonzalez
EFEmilio García Fernández
Emilio García Fernández
TVTeresa Valero
Teresa Valero
MCMaría Victoria Cano-Cortés
María Victoria Cano-Cortés
Maria J. Ruedas-RamaMaria J. Ruedas-Rama
Maria J. Ruedas-Rama
Angel OrteAngel Orte
Angel Orte
Herein, we describe the synthesis and application of cross-linked polystyrene-based dual-function nano- and microparticles containing both fluorescent tags and metals. Despite containing a single dye, these particles exhibit a characteristic dual-band fluorescence emission. Moreover, these particles can be combined with different metal ions to obtain hybrid metallofluorescent particles. We demonstrate that these particles are easily nanofected into living cells, allowing them to be used for effective fingerprinting in multimodal fluorescence-based and mass spectrometry-based flow cytometry experiments. Likewise, the in situ reductions of the metal ions enable other potential uses of the particles as heterogeneous catalysts.

18 August 2018 in Bioconjugate Chemistry
Verified
Journal Article
Open access
TVTeresa Valero
Teresa Valero
ADAntonio Delgado-González
Antonio Delgado-González
JUJuan Diego Unciti-Broceta
Juan Diego Unciti-Broceta
MCMaría Victoria Cano-Cortés
María Victoria Cano-Cortés
APAna M. Pérez-López
Ana M. Pérez-López
RSRosario María Sánchez-Martín
Rosario María Sánchez-Martín
Chemical proteomics approaches are widely used to identify molecular targets of existing or novel drugs. This manuscript describes the development of a straightforward approach to conjugate azide-labeled drugs via click chemistry to alkyne-tagged cell-penetrating fluorescent nanoparticles as a novel tool to study target engagement and/or identification inside living cells. A modification of the Baeyer test for alkynes allows monitoring the Cu(I)-catalyzed azide–alkyne cycloaddition (CuAAC) reaction, guaranteeing the presence of the drug on the solid support. As a proof of concept, the conjugation of the promiscuous kinase inhibitor dasatinib to Cy5-labeled nanoparticles is presented. Dasatinib-decorated fluorescent nanoparticles efficiently inhibited its protein target SRC in vitro, entered cancer cells, and colocalized with SRC in cellulo.

12 February 2025 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
ADAlexandros P. Drainas
Alexandros P. Drainas
DMDavid R. McIlwain
David R. McIlwain
ADAlec Dallas
Alec Dallas
TCTheresa Chu
Theresa Chu
ADAntonio Delgado-González
Antonio Delgado-González
XRXavier Rovira-Clavé
Xavier Rovira-Clavé
In serology, each sample is typically tested individually, one antigen at a time. This is costly and time consuming. Serology techniques should ideally allow recurrent measurements in parallel in small sample volumes and be inexpensive and fast. Here we show that mass cytometry can be used to scale up multiplexed serology testing by leveraging polystyrene beads uniformly loaded with combinations of stable isotopes. We generated 18,480 unique isotopically barcoded beads to simultaneously detect, in a single tube with 924 serum samples, the levels of immunoglobulins G and M against 19 proteins from SARS-CoV-2 (a total of 36,960 tests in 400 nl of sample volume and 30 μl of reaction volume). As a rapid, high-throughput and cost-effective technique, serology by mass cytometry may contribute to the effective management of public health emergencies originating from infectious diseases.

12 January 2023 in Seminars in Immunopathology
Verified
Journal Article
Open access
PDF file
IFIonut-Gabriel Funingana
Ionut-Gabriel Funingana
JBJacob S. Bedia
Jacob S. Bedia
YHYing-Wen Huang
Ying-Wen Huang
AGAntonio Delgado Gonzalez
Antonio Delgado Gonzalez
KDKenyi Donoso
Kenyi Donoso
WFWendy J. Fantl
Wendy J. Fantl
High-grade serous ovarian cancer (HGSOC) is the most lethal gynecological malignancy. Its diagnosis at advanced stage compounded with its excessive genomic and cellular heterogeneity make curative treatment challenging. Two critical therapeutic challenges to overcome are carboplatin resistance and lack of response to immunotherapy. Carboplatin resistance results from diverse cell autonomous mechanisms which operate in different combinations within and across tumors. The lack of response to immunotherapy is highly likely to be related to an immunosuppressive HGSOC tumor microenvironment which overrides any clinical benefit. Results from a number of studies, mainly using transcriptomics, indicate that the immune tumor microenvironment (iTME) plays a role in carboplatin response. However, in patients receiving treatment, the exact mechanistic details are unclear. During the past decade, multiplex single-cell proteomic technologies have come to the forefront of biomedical research. Mass cytometry or cytometry by time-of-flight, measures up to 60 parameters in single cells that are in suspension. Multiplex cellular imaging technologies allow simultaneous measurement of up to 60 proteins in single cells with spatial resolution and interrogation of cell–cell interactions. This review suggests that functional interplay between cell autonomous responses to carboplatin and the HGSOC immune tumor microenvironment could be clarified through the application of multiplex single-cell proteomic technologies. We conclude that for better clinical care, multiplex single-cell proteomic technologies could be an integral component of multimodal biomarker development that also includes genomics and radiomics. Collection of matched samples from patients before and on treatment will be critical to the success of these efforts.